Clinical Trial Update: Investigation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LIM-0705 in Male Subjects With Impaired Glucose Tolerance [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating LIM-0705 in male subjects with impaired glucose tolerance has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Glucose Tolerance

Drugs mentioned

• LIM-0705

Snippet

Sponsor: Limerick BioPharma | Conditions: Impaired Glucose Tolerance | Phase 1 | Status: WITHDRAWN